Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities
Regulatory T cells (Tregs) are key mediators of peripheral self-tolerance and alterations in their frequencies, stability, and function have been linked to autoimmunity. The antigen-specific induction of Tregs is a long-envisioned goal for the treatment of autoimmune diseases given reduced side effe...
Main Authors: | Isabelle Serr, Felix Drost, Benjamin Schubert, Carolin Daniel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.712870/full |
Similar Items
-
Advances in Human Immune System Mouse Models for Personalized Treg-Based Immunotherapies
by: Isabelle Serr, et al.
Published: (2021-02-01) -
Do natural Treg become activated to antigen specific Treg in transplantation and in autoimmunity?
by: Bruce Milne Hall, et al.
Published: (2013-08-01) -
Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision
by: Patrick R. Adair, et al.
Published: (2017-09-01) -
Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
by: Qunfang Zhang, et al.
Published: (2018-10-01) -
Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation
by: Claudia Selck, et al.
Published: (2021-05-01)